These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
15. Differential response of SHH-expressing adult medulloblastomas to the sonic hedgehog inhibitor vismodegib: whole-genome analysis. Lou E; Nelson AC; Kool M Cancer Biol Ther; 2019; 20(11):1398-1402. PubMed ID: 31423907 [TBL] [Abstract][Full Text] [Related]
16. Medulloblastoma with transitional features between Group 3 and Group 4 is associated with good prognosis. Łastowska M; Trubicka J; Niemira M; Paczkowska-Abdulsalam M; Karkucińska-Więckowska A; Kaleta M; Drogosiewicz M; Perek-Polnik M; Krętowski A; Cukrowska B; Grajkowska W; Dembowska-Bagińska B; Matyja E J Neurooncol; 2018 Jun; 138(2):231-240. PubMed ID: 29427151 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of WNT signaling attenuates self-renewal of SHH-subgroup medulloblastoma. Rodriguez-Blanco J; Pednekar L; Penas C; Li B; Martin V; Long J; Lee E; Weiss WA; Rodriguez C; Mehrdad N; Nguyen DM; Ayad NG; Rai P; Capobianco AJ; Robbins DJ Oncogene; 2017 Nov; 36(45):6306-6314. PubMed ID: 28714964 [TBL] [Abstract][Full Text] [Related]
18. CD271 Liang L; Coudière-Morrison L; Tatari N; Stromecki M; Fresnoza A; Porter CJ; Del Bigio MR; Hawkins C; Chan JA; Ryken TC; Taylor MD; Ramaswamy V; Werbowetski-Ogilvie TE Cancer Res; 2018 Aug; 78(16):4745-4759. PubMed ID: 29930101 [TBL] [Abstract][Full Text] [Related]
19. Medulloblastoma in Adults: Cytogenetic Phenotypes Identify Prognostic Subgroups. Goschzik T; Zur Muehlen A; Doerner E; Waha A; Friedrich C; Hau P; Pietsch T J Neuropathol Exp Neurol; 2021 Apr; 80(5):419-430. PubMed ID: 33870422 [TBL] [Abstract][Full Text] [Related]
20. The evolution of medulloblastoma therapy to personalized medicine. Sengupta S; Pomeranz Krummel D; Pomeroy S F1000Res; 2017; 6():490. PubMed ID: 28713553 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]